PT Darya-Varia Laboratoria Tbk (IDX:DVLA)

Revenue by Segment

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Prescription Drugs	666.22B	705.23B	708.42B	638.67B	660.42B
Prescription Drugs Growth	-5.53%	-0.45%	10.92%	-3.29%	4.45%
Consumer Health Products	1.26T	1.15T	961.78B	1.06T	942.75B
Consumer Health Products Growth	9.10%	20.02%	-9.03%	12.15%	11.44%
Services	49.54B	26.51B	26.98B	-	-
Services Growth	86.89%	-1.76%	-	-	-
Export & Toll Manufacturing	256.69B	201.58B	193.70B	221.12B	297.72B
Export & Toll Manufacturing Growth	27.34%	4.06%	-12.40%	-25.73%	-15.29%
Total	2.23T	2.09T	1.89T	1.92T	1.90T
Total Growth	6.90%	10.40%	-1.36%	0.85%	3.89%

Revenue by Geography

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Indonesia	1.99T	1.90T	1.72T	1.71T	1.65T
Indonesia Growth	4.73%	10.86%	0.21%	4.18%	10.39%
Export	222.20B	183.26B	173.13B	202.97B	255.64B
Export Growth	21.25%	5.85%	-14.70%	-20.60%	-24.65%
Total	2.22T	2.09T	1.89T	1.92T	1.90T
Total Growth	6.18%	10.40%	-1.36%	0.85%	3.89%

Source: S&P Global Market Intelligence.